Desma Pharm Frag 176–191 HGH Fragment

Pack Size: 5 Vials × 6 mg

High‑purity HGH Fragment 176–191 manufactured in Italy. Supplied as 5 vials × 6 mg with strict quality control and full batch documentation. Designed for research and laboratory use.

Description:

Desma Pharm Frag 176–191 HGH Fragment is a precisely synthesized peptide fragment corresponding to amino acids 176–191 of Human Growth Hormone (HGH). Manufactured in Italy under advanced pharmaceutical production standards, this product is engineered for consistency, purity, and reliability required by research professionals.

Each pack contains 5 sterile vials, 6 mg per vial, enabling flexible research protocols, reduced handling risk, and improved batch traceability. Every batch undergoes rigorous analytical testing to ensure identity, purity, and reproducibility.

Desma Pharmaceuticals focuses exclusively on peptide manufacturing—allowing us to deliver dependable quality, transparent documentation, and global availability through desmapharm.com.

Key Features

• HGH Fragment 176–191 peptide sequence
• Italian manufacturing
• High‑purity peptide synthesis
• 5 vials × 6 mg for flexible research use
• Batch‑tested with quality verification
• Secure global shipping

Intended Use (Important)

For research and laboratory use only.
Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease.

Handling & Storage Guidelines (How to Use – Research Context)

• Reconstitute only in a controlled laboratory environment using appropriate sterile techniques
• Use laboratory‑grade solvents and equipment
• Avoid repeated freeze–thaw cycles
• Store unopened vials as recommended by laboratory standards
• Handle according to institutional research and safety protocols

(No dosage or administration instructions are provided, in compliance with research‑only regulations.)

Research Characteristics & Advantages

• Fragment‑specific HGH sequence for targeted research
• High analytical purity supporting reproducible results
• Consistent batch‑to‑batch manufacturing
• Reduced degradation risk due to vialized packaging
• Suitable for peptide structure, stability, and mechanism studies

Quality Assurance

• Manufactured in Italy
• Identity and purity testing performed
• Controlled production environment
• Documentation available upon request (COA)

Comparison: Desma Pharm vs Typical Market Alternatives

Frequently Asked Questions (FAQ)

Q1: What is HGH Fragment 176–191?
It is a peptide fragment derived from amino acids 176–191 of Human Growth Hormone, commonly studied in laboratory research settings.

Q2: Is this product pharmaceutical or clinical grade?
This product is supplied strictly for research use only and is not approved for clinical or therapeutic use.

Q3: Where is Desma Pharm Frag 176–191 manufactured?
All Desma Pharmaceuticals peptides are manufactured in Italy.

Q4: Do you ship internationally?
Yes, we ship worldwide through our secure online platform.